Phase 2 Malignant Neoplasm of Prostate Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

Malignant Neoplasm of ProstateLocally Advanced Prostate Cancer

Angela Y. Jia, MD PhD45 enrolled1 locationNCT06574880

Recruiting

Phase 2

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Prostate CancerMalignant Neoplasm of ProstateSecondary Malignant Neoplasm of Prostate

Case Comprehensive Cancer Center200 enrolled2 locationsNCT06150417

Recruiting

Phase 2

SRT in Combination With Pembrolizumab in Patients With Recurrent Prostate Cancer After Radical Prostatectomy

Urologic CancerBiochemical Recurrence of Malignant Neoplasm of Prostate

Prof. Dr. med. Christian Gratzke49 enrolled1 locationNCT04931979